Market Overview:
The global tick-borne encephalitis vaccine market is expected to grow at a CAGR of 9.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of tick-borne encephalitis, rising demand for pediatric and adult vaccines, and growing awareness about traveler vaccines. The global tick-borne encephalitis vaccine market is segmented on the basis of type into European TBE virus, Far Eastern TBE virus, and Siberian TBE virus. The European TBE virus segment is expected to account for the largest share of the global tick-borne encephalitis vaccine market in 2018. This segment is also projected to grow at a CAGR of 9.8% during the forecast period from 2018 to 2030.
Product Definition:
A vaccine is a preparation of dead or weakened germs, viruses, or other organisms that is given to help the body build immunity to a disease.
European TBE Virus:
European TBE Virus, also known as tick-borne encephalitis virus or Calymmatia virus is a neurotropic arthropod borne viral infection. The disease caused by the virus is called European Tick-Borne Encephalitis (ETBE) and can affect any person who comes in contact with the infected ticks.
Far Eastern TBE Virus:
The far eastern tbe virus (FETV) is a single-stranded DNA (ssDNA)-based virus belonging to the family of Orthodromic Entry Viruses (OEVs). The FETV genome consists of 3 open reading frames, designated as RTA, RTB and RTC. These three regions are involved in viral replication and are therefore subject to vaccine development against this disease.
Application Insights:
The adult vaccines segment held the largest share of the global market in 2017. The growing number of adults traveling to endemic regions for TBE is anticipated to contribute significantly towards growth. Moreover, continuous R&D efforts by major players for development of a safe and effective vaccine is expected to drive demand over the forecast period.
The pediatric vaccines segment was estimated at USD 120 million in 2017 owing to high incidence rates of tick-borne encephalitis among children across the globe. According to WHO, around 50% - 80% cases have been reported from developing countries like India and China which are presumed to be under-reported due largely on lack of awareness about symptoms amongst affected individuals resulting in delayed diagnosis and treatment which subsequently hampers market growth during estimation years.
Tick paralysis also known as deer disease or Deer Fever occurs mostly during summer season when male deer become active after mating season leadingto increased infection risks among people living in proximity with infected animals or spending time outdoors between May.
Regional Analysis:
Europe dominated the global market in 2017, with a revenue share of over 40.0%. This can be attributed to the presence of a robust healthcare infrastructure, high disease prevalence rate, and favorable government initiatives pertaining to vaccination. Moreover, Europe is home to several multinational vaccine manufacturers including GlaxoSmithKline plc., F. Hoffmann-La Roche AG., Merck Group and Sanofi Pasteur MSD.
Growth Factors:
- Increasing incidence of tick-borne encephalitis (TBE) across the globe
- Growing awareness about TBE and its preventive measures
- Rising demand for TBE vaccines due to increasing travel and outdoor activities
- Technological advancements in vaccine development process
- Growing investments by key players in R&D of TBE vaccines
Scope Of The Report
Report Attributes
Report Details
Report Title
Tick-borne Encephalitis Vaccine Market Research Report
By Type
European TBE Virus, Far Eastern TBE Virus, Siberian TBE Virus
By Application
Pediatric Vaccines, Adult Vaccines, Traveler Vaccines
By Companies
Pfizer, Encephalitis, Cochrane Collaboration, Sonic HealthPlus, Superdrug Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Tick-borne Encephalitis Vaccine Market Report Segments:
The global Tick-borne Encephalitis Vaccine market is segmented on the basis of:
Types
European TBE Virus, Far Eastern TBE Virus, Siberian TBE Virus
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pediatric Vaccines, Adult Vaccines, Traveler Vaccines
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Encephalitis
- Cochrane Collaboration
- Sonic HealthPlus
- Superdrug Health
Highlights of The Tick-borne Encephalitis Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- European TBE Virus
- Far Eastern TBE Virus
- Siberian TBE Virus
- By Application:
- Pediatric Vaccines
- Adult Vaccines
- Traveler Vaccines
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tick-borne Encephalitis Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Tick-borne Encephalitis vaccine is a vaccine that helps protect people from getting tick-borne encephalitis (TBE). TBE is a serious, life-threatening illness caused by the bite of an infected tick. The Tick-borne Encephalitis vaccine helps prevent infection with the virus that causes TBE.
Some of the major companies in the tick-borne encephalitis vaccine market are Pfizer, Encephalitis, Cochrane Collaboration, Sonic HealthPlus, Superdrug Health.
The tick-borne encephalitis vaccine market is expected to register a CAGR of 9.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tick-borne Encephalitis Vaccine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tick-borne Encephalitis Vaccine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tick-borne Encephalitis Vaccine Market - Supply Chain
4.5. Global Tick-borne Encephalitis Vaccine Market Forecast
4.5.1. Tick-borne Encephalitis Vaccine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tick-borne Encephalitis Vaccine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tick-borne Encephalitis Vaccine Market Absolute $ Opportunity
5. Global Tick-borne Encephalitis Vaccine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Type
5.3.1. European TBE Virus
5.3.2. Far Eastern TBE Virus
5.3.3. Siberian TBE Virus
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tick-borne Encephalitis Vaccine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Application
6.3.1. Pediatric Vaccines
6.3.2. Adult Vaccines
6.3.3. Traveler Vaccines
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tick-borne Encephalitis Vaccine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tick-borne Encephalitis Vaccine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tick-borne Encephalitis Vaccine Demand Share Forecast, 2019-2026
9. North America Tick-borne Encephalitis Vaccine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Application
9.4.1. Pediatric Vaccines
9.4.2. Adult Vaccines
9.4.3. Traveler Vaccines
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Type
9.7.1. European TBE Virus
9.7.2. Far Eastern TBE Virus
9.7.3. Siberian TBE Virus
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tick-borne Encephalitis Vaccine Demand Share Forecast, 2019-2026
10. Latin America Tick-borne Encephalitis Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Application
10.4.1. Pediatric Vaccines
10.4.2. Adult Vaccines
10.4.3. Traveler Vaccines
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Type
10.7.1. European TBE Virus
10.7.2. Far Eastern TBE Virus
10.7.3. Siberian TBE Virus
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tick-borne Encephalitis Vaccine Demand Share Forecast, 2019-2026
11. Europe Tick-borne Encephalitis Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Application
11.4.1. Pediatric Vaccines
11.4.2. Adult Vaccines
11.4.3. Traveler Vaccines
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Type
11.7.1. European TBE Virus
11.7.2. Far Eastern TBE Virus
11.7.3. Siberian TBE Virus
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tick-borne Encephalitis Vaccine Demand Share, 2019-2026
12. Asia Pacific Tick-borne Encephalitis Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Application
12.4.1. Pediatric Vaccines
12.4.2. Adult Vaccines
12.4.3. Traveler Vaccines
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Type
12.7.1. European TBE Virus
12.7.2. Far Eastern TBE Virus
12.7.3. Siberian TBE Virus
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tick-borne Encephalitis Vaccine Demand Share, 2019-2026
13. Middle East & Africa Tick-borne Encephalitis Vaccine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Application
13.4.1. Pediatric Vaccines
13.4.2. Adult Vaccines
13.4.3. Traveler Vaccines
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tick-borne Encephalitis Vaccine Market Size and Volume Forecast by Type
13.7.1. European TBE Virus
13.7.2. Far Eastern TBE Virus
13.7.3. Siberian TBE Virus
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tick-borne Encephalitis Vaccine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Tick-borne Encephalitis Vaccine Market: Market Share Analysis
14.2. Tick-borne Encephalitis Vaccine Distributors and Customers
14.3. Tick-borne Encephalitis Vaccine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Encephalitis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cochrane Collaboration
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sonic HealthPlus
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Superdrug Health
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
